Literature DB >> 32281945

(H)Elping nerve growth factor: Elp1 inhibits TrkA's phosphatase to maintain retrograde signaling.

David R Kaplan1,2, William C Mobley3.   

Abstract

Nerve growth factor (NGF) regulates many aspects of neuronal biology by retrogradely propagating signals along axons to the targets of those axons. How this occurs when axons contain a plethora of proteins that can silence those signals has long perplexed the neurotrophin field. In this issue of the JCI, Li et al. suggest an answer to this vexing problem, while exploring why the Elp1 gene that is mutated in familial dysautonomia (FD) causes peripheral neuropathy. They describe a distinctive function of Elp1 as a protein that is required to sustain NGF signaling by blocking the activity of its phosphatase that shuts off those signals. This finding helps explain the innervation deficits prominent in FD and reveals a unique role for Elp1 in the regulation of NGF-dependent TrkA activity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32281945      PMCID: PMC7190902          DOI: 10.1172/JCI136162

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  Signaling mechanisms underlying dendrite formation.

Authors:  Freda D Miller; David R Kaplan
Journal:  Curr Opin Neurobiol       Date:  2003-06       Impact factor: 6.627

Review 2.  Axon Transport and Neuropathy: Relevant Perspectives on the Etiopathogenesis of Familial Dysautonomia.

Authors:  Warren G Tourtellotte
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

3.  Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity.

Authors:  Yuki Fujita; Shota Endo; Toshiyuki Takai; Toshihide Yamashita
Journal:  EMBO J       Date:  2011-03-01       Impact factor: 11.598

Review 4.  Neurotrophin signal transduction in the nervous system.

Authors:  D R Kaplan; F D Miller
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

5.  Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia.

Authors:  Pierre Close; Nicola Hawkes; Isabelle Cornez; Catherine Creppe; Charles A Lambert; Bernard Rogister; Ulrich Siebenlist; Marie-Paule Merville; Susan A Slaugenhaupt; Vincent Bours; Jesper Q Svejstrup; Alain Chariot
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

6.  Retrograde nerve growth factor signaling abnormalities in familial dysautonomia.

Authors:  Lin Li; Katherine Gruner; Warren G Tourtellotte
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

7.  One at a time, live tracking of NGF axonal transport using quantum dots.

Authors:  Bianxiao Cui; Chengbiao Wu; Liang Chen; Alfredo Ramirez; Elaine L Bearer; Wei-Ping Li; William C Mobley; Steven Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-14       Impact factor: 11.205

8.  Trafficking the NGF signal: implications for normal and degenerating neurons.

Authors:  Jean-Dominique Delcroix; Janice Valletta; Chenbiao Wu; Charles L Howe; Chun-Fai Lai; John D Cooper; Pavel V Belichenko; Ahmad Salehi; William C Mobley
Journal:  Prog Brain Res       Date:  2004       Impact factor: 2.453

9.  Phosphatidylserine Ameliorates Neurodegenerative Symptoms and Enhances Axonal Transport in a Mouse Model of Familial Dysautonomia.

Authors:  Shiran Naftelberg; Ziv Abramovitch; Shani Gluska; Sivan Yannai; Yuvraj Joshi; Maya Donyo; Keren Ben-Yaakov; Tal Gradus; Jonathan Zonszain; Chen Farhy; Ruth Ashery-Padan; Eran Perlson; Gil Ast
Journal:  PLoS Genet       Date:  2016-12-20       Impact factor: 5.917

Review 10.  The Many Faces of Elongator in Neurodevelopment and Disease.

Authors:  Marija Kojic; Brandon Wainwright
Journal:  Front Mol Neurosci       Date:  2016-11-01       Impact factor: 5.639

View more
  1 in total

1.  Retrograde nerve growth factor signaling abnormalities and the pathogenesis of familial dysautonomia.

Authors:  Soumitra Ghosh; Lin Li; Warren G Tourtellotte
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.